![]() |
Atrial fibrillation Hypertension (high blood pressure) Pulmonary hypertension Acute myocardial infarction (AMI) Chronic heart failure Syncope |
![]() |
Hypertension In the months and years before a medical condition like a stroke or infarction, hypertension causes damage to the different organs and systems. There are clinical conditions requiring the initiation of a drug therapy even with levels not within the range of hypertension. Blood pressure levels equal or higher than 140 mm Hg with regards to systolic pressure or equal or higher than 90 mm Hg for diastolic require therapeutic intervention Atrial fibrillation Depending on its presentation, atrial fibrillation is classified into 3 main forms: Pulmonary hypertension Acute myocardial infarction Chronic heart failure In the advanced stages of failure, fluids start building up in the liver and in the gastrointestinal tract and there is the onset of: In this phase, the patient cannot perform normal daily activities and the consequence of a further worsening of the chronic heart failure is acute heart failure Syncope |
![]() |
Atrial fibrillation In both cases, by following appropriate therapies and undergoing regular specialist follow-ups, the patient can easily live with the condition Hypertension When lifestyle modifications are not sufficient to reduce blood pressure levels it is necessary to use drug therapy. By customising the treatment for each patient it is possible to ensure an excellent quality of life by limiting or eliminating side effects Pulmonary hypertension Chronic heart failure Syncope |
![]() |
Atrial fibrillation Hypertension Pulmonary hypertension Acute myocardial infarction Chronic heart failure Syncope |
![]() |
Atrial fibrillation Hypertension Pulmonary hypertension Acute myocardial infarction Chronic heart failure Syncope |
![]() |
In overweight patients with suspected concomitant sleep apnoea, we recommend a careful assessment of the problem, which, if present, requires the use of a home ventilator Associations “Cuore Vivo Onlus” With regards to hypertension, there are several national and international associations, like: SIIA: Società Italiana Ipertensione Arteriosa - Italian Society for Hypertension |
![]() |
Medical associations and companies manufacturing antihypertensive drugs sponsor randomised clinical trials aimed at defining both diagnostic and therapeutic aspects (genetic studies or studies using communication technologies to help treatment adherence) With regards to pulmonary hypertension, INRCA is currently working on the Victoria trial with the Cardiology Clinic. The study will assess the treatment with vericiguat (an sGC receptor agonist belonging to the class of drugs approved for the treatment of pulmonary hypertension) in patients with severe left ventricular dysfunction For many years the Cardiology/CCU/Telecardiology Operational Unit has taken part in multicentre national and international studies involving patients with acute myocardial infarction. ATPCI and POSTER are currently ongoing, while in recent years Elderly and Elderly II tried to search for the best treatment for infarction in elderly patients With regards to syncope, a research project in collaboration with neurologists has just started to identify the silent phases of atrial fibrillation in patients with high cardioembolic risk (CHADVASC score >2) in sinus rhythm with cryptogenic stroke without apparent history of fibrillation. These patients will be implanted with a loop-recorder (a sort of Holter ECG connected via online telemetry) that identifies atrial fibrillation phases and therefore allows the appropriate therapeutic switch |
IRCCS INRCA